← Eichor
Study identifier: NCT06183541 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of Pericapsular Nerve Group Block Applied in Patients Undergoing Hip Fracture Surgery.

Condition: Hip Fractures · Pain, Postoperative  ·  Sponsor: Umraniye Education and Research Hospital

PhaseNA
Planned participants70
Who can joinAll sexes, 30 Years to 85 Years
Healthy volunteersNo

About this study

In this study, it was aimed to compare the multimodal analgesia application or the pericapsular nerve group (PENG) block methods in patients undergoing hip surgery. The effectiveness and benefit rate of the PENG block in postoperative pain will be evaluated. Postoperative pain, need for additional analgesia, range of motion of the hip joint, mobilization time, length of hospital time and adverse events in patients undergoing hip fracture surgery with and without PENG block will be investigated.

This description comes directly from the study's public registry record.

Talk to the study team

Zeliha Tuncel, MD  ·  +905053577483  ·  zelihalara@yahoo.com

Hale Arkan Tuna, MD  ·  +905303705619  ·  halearkan@yahoo.com.tr

Always discuss trial participation with your own doctor first.

Locations (2)

Umraniye Education and Research HospitalIstanbul, Umraniye, Turkey (Türkiye)Recruiting
UmraniyeERHIstanbul, Umraniye, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06183541